Professor John Eisman
Professor Eisman’s major contributions include the first clinical assay of active vitamin D, importance of vitamin D in cancer, then strong genetic determination of bone mass, identification of the first candidate gene and role in international osteoporosis GWAS. He demonstrated the importance of all fragility fractures in men and women, their relationship to premature death […]
Professor Simon Finfer
Professor Simon Finfer is recognised internationally for excellence as an innovative, researcher, educator, mentor and editor. He was a founding member of the ANZICS Clinical Trials Group; Chair from 2000 – 2004. He led research that has changed clinical practice around the world. He is a Guest Editor for The New England Journal of Medicine; […]
Professor Alan Finkel
As Chancellor of Monash University and President of ATSE, Professor Alan Finkel actively promotes education and research in the broadest sense including the substantial medical research endeavour at the University. As a research neuroscientist then businessman Alan developed advanced voltage clamp, patch clamp, data acquisition and imaging systems that contributed to the worldwide benefits from […]
Professor Nicholas Fisk
Professor Fisk has a sustained record of clinical innovation as an obstetrician/fetal medicine specialist. He has pioneered significant advances in understanding fetoplacental disease and its treatment including characterising early human fetal stem cell populations, documenting “fetal pain” and its blockade by opioid analgesia, and unravelling the vascular basis of twin-to-twin transfusion syndrome. Professor Fisk has […]
Professor Simon Foote
Professor Simon Foote was appointed as Director of the John Curtin School of Medical Research at the Australian National University in November 2014. His prime research interests are in the areas of infectious disease, specifically malaria, where his team is developing new antimalarials using a genetics approach. He has worked on the genetics of numerous […]
Professor Ian Frazer
Professor Ian Frazer works to raise awareness and funds for medical research through his role with The University of Queensland (UQ) and as Chair of the TRI Foundation Board. He is also the current Chair of the advisory board advising the commonwealth government on the use of the Medical Research Future Fund, a member of […]
Professor Frank Gannon
Professor Frank Gannon is an international thought leader and researcher. His contributions have been recognised by election to EMBO, Acadamiae Europaeae, Royal Irish Academy, European Academy of Cancer Sciences, Mexican Academy of Medicine and Honorary doctorates from three universities. He leads a major medical research Institute active in discovery and translational research. His research has […]
Professor Paul Glasziou
Paul Glasziou FRACGP, PhD is Professor of Evidence-Based Medicine at Bond University and a part-time General Practitioner. He was the Director of the Centre for Evidence-Based Medicine in Oxford from 2003-2010. His key interests include identifying and removing the barriers to using high quality research in everyday clinical practice, reducing waste in research, and preventing […]
Professor Michael Good
Professor Michael Good AO is an international leader in vaccine research and development. For over 25 years he has studied immunity to the malaria parasite and to Streptococcus pyogenes with the goal of identifying novel vaccine strategies. These organisms are responsible for the loss of over 1.5 million lives each year. He is currently undertaking […]
Professor Robert Graham
Professor Robert M. Graham is internationally regarded for his contributions to our understanding of cardiovascular homeostatic and disease mechanisms via adrenergic receptors and coupled signal transduction pathways; studies that have utilised the tools of molecular and cell biology, biochemistry and biophysics. Nationally he is recognised for establishing a leading cardiovascular research institute, which also provides […]
Professor Adele Green
Professor Green has provided an unparalleled body of evidence regarding the causes and preventability of cancers of the skin, the latter forming the basis of clinical and public health prevention strategies in the USA, Europe, Australia and of WHO recommendations. For two and half decades she has served on numerous health and medical science boards […]
Professor Robyn Guymer
Professor Guymer is Australia’s only academic ophthalmologist to focus exclusively on age-related macular degeneration (AMD), the most common cause of poor vision in our society. She established new AMD treatment clinics at the Royal Victorian Eye and Ear Hospital (the first Australian public hospital to do so); delivered state-of-the-art imaging and functional techniques; and contributed […]
Professor Wayne Hall
Professor Wayne Hall is internationally-recognised in the fields of addiction and mental health. He has made significant and sustained contributions advancing understanding of the epidemiology of alcohol and drug use, mental disorders, and harms related to alcohol and drug use. He has made major contributions to the formulation of Australian national drug and alcohol policy […]
Professor Glenda Halliday
Professor Glenda Halliday’s research on Parkinson’s disease (PD) and dementia with Lewy bodies is incorporated into diagnostic research criteria-only Australian on current task force redefining PD diagnosis. In frontotemporal dementia, performed the 1st large-scale clinicopathological and survival analyses, developed a disease severity staging scheme-research also incorporated into diagnostic criteria and international studies identifying novel genes […]
Professor Leonard Harrison
Professor Len Harrison was among the first to characterise the insulin receptor, including its clinical relevance. He inaugurated Australian research into the pathogenesis, pre-clinical diagnosis and prevention of type 1 diabetes (T1D). He discoveries include: mechanisms of pancreatic beta-cell destruction, the primacy of insulin as an autoantigen, protective immune tolerance induced by insulin, T-cell epitopes […]
Professor Ian Hickie
Professor Hickie has led evidence-based public health and clinical responses to common mental health problems such as anxiety, depression and alcohol misuse. He has initiated community programs to reduce death and disability due to depression and linked physical health problems. He has led clinical and e-health strategies for early intervention in younger persons with mental […]
Professor Geoffrey Hill
Professor Douglas Hilton
Professor Douglas Hilton is an expert in the field of molecular regulation of blood cell production and cytokine signal transduction. His creative discovery spans four distinct areas of molecular haematology: leukaemia inhibitory factor, cytokine receptor family, suppressors of cytokine signalling, and identification of haematopoietic regulators through a large-scale forward mutagenesis screen. He has applied these […]
Professor Michael Horowitz
Professor Michael Horowitz was appointed to a Personal Chair at the University of Adelaide in 1995, and has been the Director of the Endocrine and Metabolic Unit at the Royal Adelaide Hospital since 1997. His research activities are almost exclusively clinically based, relate primarily to gastrointestinal motor sensory and hormonal function, particularly in the context […]
Professor Timothy Hughes
Professor Hughes is an international expert in the biology and treatment of leukaemia. He led the establishment of the molecular response criteria that are used world-wide to measure response in chronic myeloid leukaemia (CML) and has led many of the key Global and National trials. His group has successfully developed predictive bioassays that influence the […]